LIVE MARKET TRACKER :   BSE SENSEX   32584.35      |    NSE NIFTY 10210.85    
GLOBAL MARKETS :  NASDAQ 6624.22   +0.01%    |    FSI London 7542.87   +0.36%    |    NIKKEI Japan 21416.58   +0.25%
  USD GBP EUR CAD AUD INR
USD - 0.7567 0.8477 1.2471 1.2734 65.0890
GBP 1.3214 - 1.1200 1.6479 1.6826 86.0490
EUR 1.1800 0.8930 - 1.4714 1.5024 76.7966
CAD 0.8025 0.6072 0.6798 - 1.0215 52.2120
AUD 0.7854 0.5945 0.6658 0.9794 - 51.0900
INR 0.0154 0.0116 0.0130 0.0192 0.0196 -
Indian-Commodity  :  Corporate  :  M&M's arm to recall Rexton SUV to rectify faulty rear driveshaft in India

M&M's arm to recall Rexton SUV to rectify faulty rear driveshaft in India (18-Aug-2016)

Mahindra and Mahindra's (M&M) South Korean subsidiary SsangYong Motor, has decided to recall the Rexton SUV in India.  The vehicles covered under this recall are all units of the Rexton SUV manufactured before September 2014. The company will contact the customers of the affected cars to fix the faulty rear driveshaft in the SUV. The inspection and subsequent corrective measures will be carried out free of cost. The Rexton marked the Korean manufacturer's entry into the Indian market, back in 2012. Despite not being a volume seller, it has continued to be the company's poster boy in India and has helped M&M keep the SsangYong brand alive here.

M&M is the flagship company of the Mahindra Group, a multinational conglomerate based in Mumbai, India. Amongst the various business interests of its parent group, the company is mainly involved in the automobile manufacturing. It is one of the leading auto companies of India.


Top News Today
Suven Life Sciences secures product patent in Singapore
(18-Oct-2017)

Suven Life Sciences secures product patent in SingaporeSuven Life Sciences has secured one product patent from Singapore corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents......click on news to read complete article.

Jubilant Life Sciences issues commercial papers worth Rs 50 crore
(18-Oct-2017)

Jubilant Life Sciences issues commercial papers worth Rs 50 croreJubilant Life Sciences has issued Commercial Papers (CPs) aggregating to Rs 50 crore on October 17, 2017. The company has issued two commercial papers of Rs 25 crore each providing an interest rate of......click on news to read complete article.

Peninsula Land receives Rs 200 crore from Godrej Skyline for Pune land
(18-Oct-2017)

Peninsula Land receives Rs 200 crore from Godrej Skyline for Pune landPeninsula Land has received Rs 200 crore out of the total consideration of Rs 226 crore from Godrej Skyline Developers for sale of property situated at Village Mamurdi, Taluka Haveli, District - Pune,......click on news to read complete article.

International Stock News
Asian markets trade mostly lower in early deals on Wednesday
(18-Oct-2017)

Asian markets trade mostly lower in early deals on WednesdayMost of the Asian equity benchmarks are trading lower in the early deals on Wednesday with investors trading cautiously as China's President Xi Jinping spoke at the beginning of the Communist Party's 19th......click on news to read complete article.

US markets closed mostly higher on round of positive earnings report
(18-Oct-2017)

US markets closed mostly higher on round of positive earnings reportThe US markets closed mostly higher on Tuesday, with both the Dow and the S&P 500 finishing at records as a round of positive earnings report from major companies boosted positive sentiment and......click on news to read complete article.

Asian markets trade mostly higher in early deals on Tuesday
(17-Oct-2017)

Asian markets trade mostly higher in early deals on TuesdayMost of the Asian equity benchmarks are trading in green in the early deals on Tuesday, with the fresh record highs on Wall Street and firm commodity prices boosting investors' sentiments. Comments by......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.